Peter E Lonergan
Overview
Explore the profile of Peter E Lonergan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
644
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Washington 3rd S, Lonergan P, Odisho A, Meng M, Porten S
Cancer Med
. 2024 Mar;
13(7):e7116.
PMID: 38553953
Background: Financial toxicity of bladder cancer care may influence how patients utilize healthcare resources, from emergency department (ED) encounters to office visits. We aim to examine whether greater household net...
3.
4.
Khan J, McLoughlin L, Lonergan P
Urol Pract
. 2023 Oct;
10(6):594-595.
PMID: 37856722
No abstract available.
5.
Washington 3rd S, Lonergan P, Cowan J, Zhao S, Broering J, Palmer N, et al.
Cancer Med
. 2023 Sep;
12(18):19234-19244.
PMID: 37724617
Introduction: We aim to characterize the magnitude of the work burden (weeks off from work) associated with prostate cancer (PCa) treatment over a 10-year period after PCa diagnosis and identify...
6.
Han J, Lee S, Lee B, Baek O, Washington 3rd S, Herlemann A, et al.
Sci Rep
. 2023 Jul;
13(1):11532.
PMID: 37460568
Although there are several decision aids for the treatment of localized prostate cancer (PCa), there are limitations in the consistency and certainty of the information provided. We aimed to better...
7.
Baskin A, Cowan J, Braun A, Lonergan P, Mohamad O, Washington 3rd S, et al.
Urol Oncol
. 2023 Jul;
41(10):429.e9-429.e14.
PMID: 37407420
Background: To report objective long-term complications and health related quality of life (HRQOL) outcomes after radical prostatectomy (RP) with and without radiation therapy (RT) for prostate cancer (CaP). Methods: We...
8.
Croghan S, Mohan H, Breen K, McGovern R, Bennett K, Boland M, et al.
JAMA Surg
. 2023 Jul;
158(8):865-873.
PMID: 37405798
Importance: Postoperative urinary retention (POUR) is a well-recognized complication of inguinal hernia repair (IHR). A variable incidence of POUR has previously been reported in this context, and contradictory evidence surrounds...
9.
Lonergan P, Baskin A, Greenberg S, Mohamad O, Washington 3rd S, Zhao S, et al.
Urology
. 2023 May;
178:114-119.
PMID: 37244430
Objective: To assess the long-term incidence of treatment-related toxicities and quality of life (QOL) outcomes associated with toxicity after external beam radiotherapy (EBRT) for prostate cancer. Methods: We identified all...
10.